BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10830726)

  • 1. Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2.
    Bougeret C; Virone-Oddos A; Adeline E; Lacroix F; Lefranc C; Ferrero L; Huet T
    Cancer Gene Ther; 2000 May; 7(5):789-98. PubMed ID: 10830726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
    Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
    Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTS1: a p53-derived chimeric tumor suppressor gene with enhanced in vitro apoptotic properties.
    Conseiller E; Debussche L; Landais D; Venot C; Maratrat M; Sierra V; Tocque B; Bracco L
    J Clin Invest; 1998 Jan; 101(1):120-7. PubMed ID: 9421473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
    Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.
    Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T
    Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
    Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
    Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
    Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
    Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis.
    Coll JL; Negoescu A; Louis N; Sachs L; Tenaud C; Girardot V; Demeinex B; Brambilla E; Brambilla C; Favrot M
    Hum Gene Ther; 1998 Sep; 9(14):2063-74. PubMed ID: 9759933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
    Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
    Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells.
    Dilla T; Velasco JA; Medina DL; González-Palacios JF; Santisteban P
    Endocrinology; 2000 Jan; 141(1):420-9. PubMed ID: 10614665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypass of abnormal MDM2 inhibition of p53-dependent growth suppression.
    Meng RD; Shih H; Prabhu NS; George DL; el-Deiry WS
    Clin Cancer Res; 1998 Jan; 4(1):251-9. PubMed ID: 9516979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
    Vassilev LT; Vu BT; Graves B; Carvajal D; Podlaski F; Filipovic Z; Kong N; Kammlott U; Lukacs C; Klein C; Fotouhi N; Liu EA
    Science; 2004 Feb; 303(5659):844-8. PubMed ID: 14704432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts.
    Kawabe S; Munshi A; Zumstein LA; Wilson DR; Roth JA; Meyn RE
    Int J Radiat Biol; 2001 Feb; 77(2):185-94. PubMed ID: 11236925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
    Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
    Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
    Xu M; Xie Y; Sheng W; Miao J; Yang J
    Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
    Eastham JA; Grafton W; Martin CM; Williams BJ
    J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.